-
Mashup Score: 0
This article is featured in Top Reads , p.[][1] [1]: /lookup/volpage/208/2079
Source: The Journal of ImmunologyCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 5
SARS-CoV-2 and its new variants are efficiently blocked by new nanobodies that are extremely heat stable and, unexpectedly, capable of promoting proper folding of proteins in bacterial cells.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3
SARS-CoV-2 and its new variants are efficiently blocked by new nanobodies that are extremely heat stable and, unexpectedly, capable of promoting proper folding of proteins in bacterial cells.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1
SARS-CoV-2 and its new variants are efficiently blocked by new nanobodies that are extremely heat stable and, unexpectedly, capable of promoting proper folding of proteins in bacterial cells.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0New promising antibodies against SARS-CoV-2 - 3 year(s) ago
An international team led by the University of Bonn (Germany) identified and further developed novel antibody fragments against the SARS coronavirus-2. These ”nanobodies” are smaller than classic antibodies penetrating the tissue better and can be produced in larger quantities. The researchers also combined the nanobodies into potentially particularly effective molecules attacking different…
Source: EurekAlert!Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 17Llama nanobodies could be a powerful weapon against COVID-19 - 4 year(s) ago
Today in Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to prevent and treat COVID-19.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Spray-On Personal Protective Equipment in the Works - 4 year(s) ago
Peter Walter, PhD: “We think of AeroNabs as a molecular form of PPE that could serve as an important stopgap until vaccines provide a more permanent solution to COVID-19.”
Source: Infection Control TodayCategories: Future of Medicine, Latest HeadlinesTweet
#JI_TopRead #AuthorChoice from Piet Gros @UniUtrecht | Multi-faceted activities of seven #nanobodies against #complement C4b #ReadTheJI #immunology #Antibodies #MolecularBiology https://t.co/SvCrJRzDPs https://t.co/Zvvl16iJXE